-M B Arvelo Researcher Activity Profile

Research Author Detailed Information 

M B Arvelo Publication Rate By Year

M B Arvelo has published 2 paper(s) in 1999, 1 paper(s) in 2002, 2 paper(s) in 2003, 1 paper(s) in 2004, 1 paper(s) in 2005, 2 paper(s) in 2006, for a total of 9 research publications in total.

M B Mb Arvelo Author Information

LAST NAME: arvelo

FIRST NAME: M B

INITIALS: mb

AFFILIATION:

Papers

M B Arvelo's Publication Record

1. The universal NF-kappaB inhibitor a20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells. Year Published: 2006
Departments of Surgery and Medicine, Beth Israel Deaconess Medical Centre Harvard Medical School, Boston, Massachusetts 022152, USA.
2. A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Year Published: 2002
Department of Surgery and Medicine, Immunobiology Research Center, Beth Israel Deaconess Medical Center, Harvard Medical School, 99 Brookline Avenue, Boston, MA 02215, USA.
3. Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function. Year Published: 2003
Immunobiology Research Center, Department of Surgery and Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. sgrey@caregroup.harvard.edu
4. A20 protects from CD40-CD40 ligand-mediated endothelial cell activation and apoptosis. Year Published: 2003
Immunobiology Research Center, Department of Surgery and Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass 02215, USA.
5. A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. Year Published: 2004
Department of Surgery and Medicine, 99 Brookline Ave, Boston MA 02215, USA.
6. A novel function for A20 in smooth muscle cells: inhibition of activation and proliferation. Year Published: 1999
Immunobiology Research Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
7. A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. Year Published: 1999
Immunobiology Research Center, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA. sgrey@caregroup.harvard.edu
8. Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells. Year Published: 2005
Division of Vascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
9. A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia. Year Published: 2006
The Immunobiology Research Center, Harvard Medical School, Boston Massachusetts, USA.